BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21975730)

  • 21. Topical nasal steroids for treating nasal polyposis in people with cystic fibrosis.
    Beer H; Southern KW; Swift AC
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD008253. PubMed ID: 26098667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
    Wood DM; Smyth AR
    Cochrane Database Syst Rev; 2006 Jan; (1):CD004197. PubMed ID: 16437476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D supplementation for cystic fibrosis.
    Ferguson JH; Chang AB
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007298. PubMed ID: 19821402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bisphosphonates for osteoporosis in people with cystic fibrosis.
    Brenckmann C; Papaioannou A
    Cochrane Database Syst Rev; 2001; (4):CD002010. PubMed ID: 11687132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral calorie supplements for cystic fibrosis.
    Smyth R; Walters S
    Cochrane Database Syst Rev; 2007 Jan; (1):CD000406. PubMed ID: 17253450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical nasal steroids for treating nasal polyposis in people with cystic fibrosis.
    Beer H; Southern KW; Swift AC
    Cochrane Database Syst Rev; 2013 Apr; (4):CD008253. PubMed ID: 23633352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.
    Tam J; Nash EF; Ratjen F; Tullis E; Stephenson A
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD007168. PubMed ID: 23852992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxygen therapy for cystic fibrosis.
    Mallory GB; Fullmer JJ; Vaughan DJ
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003884. PubMed ID: 16235344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
    Lee T; Southern KW
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005599. PubMed ID: 17443603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oscillating devices for airway clearance in people with cystic fibrosis.
    Morrison L; Agnew J
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006842. PubMed ID: 19160305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Home intravenous antibiotics for cystic fibrosis.
    Balaguer A; González de Dios J
    Cochrane Database Syst Rev; 2008 Jul; (3):CD001917. PubMed ID: 18646082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antioxidant supplementation for lung disease in cystic fibrosis.
    Ciofu O; Lykkesfeldt J
    Cochrane Database Syst Rev; 2014 Aug; (8):CD007020. PubMed ID: 25102015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxygen therapy for cystic fibrosis.
    Elphick HE; Mallory G
    Cochrane Database Syst Rev; 2009 Jan; (1):CD003884. PubMed ID: 19160226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccines for preventing influenza in people with cystic fibrosis.
    Dharmaraj P; Smyth RL
    Cochrane Database Syst Rev; 2009 Oct; (4):CD001753. PubMed ID: 19821281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sodium channel blockers for cystic fibrosis.
    Burrows E; Southern KW; Noone P
    Cochrane Database Syst Rev; 2006 Jul; (3):CD005087. PubMed ID: 16856076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term low-dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheumatoid arthritis.
    Gotzsche PC; Johansen HK
    Cochrane Database Syst Rev; 2004; 2005(3):CD000189. PubMed ID: 15266426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of anti-inflammatory medications in cystic fibrosis: trends and physician attitudes.
    Oermann CM; Sockrider MM; Konstan MW
    Chest; 1999 Apr; 115(4):1053-8. PubMed ID: 10208207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-inflammatory medications for cystic fibrosis lung disease: selecting the most appropriate agent.
    Chmiel JF; Konstan MW
    Treat Respir Med; 2005; 4(4):255-73. PubMed ID: 16086599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse effects of oral corticosteroids in relation to dose in patients with lung disease.
    Walsh LJ; Wong CA; Oborne J; Cooper S; Lewis SA; Pringle M; Hubbard R; Tattersfield AE
    Thorax; 2001 Apr; 56(4):279-84. PubMed ID: 11254818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meta-analysis of short-term low dose prednisolone versus placebo and non-steroidal anti-inflammatory drugs in rheumatoid arthritis.
    Gøtzsche PC; Johansen HK
    BMJ; 1998 Mar; 316(7134):811-8. PubMed ID: 9549450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.